Concord Drugs Limited (BOM:538965)

Concord Drugs Ratios and Metrics

Market cap in millions INR. Fiscal year is April - March.

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	May 22, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Market Capitalization	1,075	925	311	352	256	254
Market Cap Growth	256.94%	197.71%	-11.63%	37.54%	0.84%	-0.17%
Enterprise Value	1,204	1,113	501	521	428	362
Last Close Price	81.63	70.23	31.08	35.17	27.45	29.00
PE Ratio	85.93	87.70	92.45	74.47	25.95	15.91
PS Ratio	1.37	1.18	0.69	0.78	0.49	0.43
PB Ratio	2.22	1.91	0.91	1.04	0.81	0.89
P/TBV Ratio	2.22	1.91	0.91	1.04	0.81	0.89
P/FCF Ratio	-	-	22.37	-	31.71	-
P/OCF Ratio	-	-	8.35	44.39	15.38	32.75
EV/Sales Ratio	1.53	1.41	1.11	1.16	0.82	0.61
EV/EBITDA Ratio	26.44	24.44	12.12	12.88	9.36	6.37
EV/EBIT Ratio	37.78	34.93	18.54	20.93	14.52	9.24
EV/FCF Ratio	-15.18	-	36.08	-	53.05	-
Debt / Equity Ratio	0.28	0.28	0.56	0.52	0.54	0.58
Debt / EBITDA Ratio	2.99	2.99	4.65	4.33	3.71	2.89
Debt / FCF Ratio	-	-	13.85	-	21.04	-
Net Debt / Equity Ratio	0.27	0.27	0.56	0.51	0.53	0.58
Net Debt / EBITDA Ratio	2.82	2.82	4.60	4.29	3.69	2.88
Net Debt / FCF Ratio	-1.62	-1.62	13.69	-76.85	20.91	-9.73
Asset Turnover	1.13	1.13	0.73	0.77	0.91	1.11
Inventory Turnover	2.66	2.66	1.48	1.57	2.22	2.90
Quick Ratio	1.19	1.19	0.53	0.61	0.74	0.97
Current Ratio	2.53	2.53	1.56	1.79	2.01	1.77
Return on Equity (ROE)	2.55%	2.55%	0.99%	1.44%	3.28%	5.78%
Return on Assets (ROA)	2.84%	2.84%	2.73%	2.66%	3.21%	4.60%
Return on Invested Capital (ROIC)	3.98%	3.99%	2.52%	3.75%	4.98%	6.58%
Return on Capital Employed (ROCE)	5.90%	5.90%	6.90%	6.60%	8.00%	11.90%
Earnings Yield	0.98%	1.14%	1.08%	1.34%	3.85%	6.29%
FCF Yield	-7.38%	-8.57%	4.47%	-0.64%	3.15%	-6.63%
Buyback Yield / Dilution	-11.05%	-11.05%	-	-7.35%	-6.53%	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.